Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 5
2012 2
2013 2
2014 2
2015 1
2017 1
2018 1
2021 1
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Vardenafil orodispersible tablet.
Sanford M. Sanford M. Drugs. 2012 Jan 1;72(1):87-98. doi: 10.2165/11208270-000000000-00000. Drugs. 2012. PMID: 22191797 Review.
Vardenafil orodispersible tablet (ODT) is a supralingual formulation of vardenafil that is available for the on-demand treatment of erectile dysfunction. The pharmacokinetics of vardenafil ODT are not equivalent to those of the vardenafil film-c …
Vardenafil orodispersible tablet (ODT) is a supralingual formulation of vardenafil that is available for the on-demand …
Efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction in elderly men and those with underlying conditions: an integrated analysis of two pivotal trials.
Sperling H, Gittelman M, Norenberg C, Ulbrich E, Ewald S. Sperling H, et al. J Sex Med. 2011 Jan;8(1):261-71. doi: 10.1111/j.1743-6109.2010.02005.x. Epub 2010 Aug 30. J Sex Med. 2011. PMID: 20807322
AIM: To determine the efficacy and safety of a new orodispersible tablet (ODT) formulation of vardenafil for the treatment of ED, and whether age, or the presence of underlying conditions affects treatment outcomes. ...RESULTS: Of the 701 men randomized (51% aged 65 …
AIM: To determine the efficacy and safety of a new orodispersible tablet (ODT) formulation of vardenafil for the treatment of …
Enhancement and evaluation of vardenafil hydrochloride trihydrate absorption in orodispersible tablet formulations: Establishment of in vitro, in vivo correlation and bioequivalence study.
Gan KZ, Widodo RT, Chik Z, Nordin ML, Bin LK. Gan KZ, et al. Chem Biol Interact. 2025 Nov 1;421:111745. doi: 10.1016/j.cbi.2025.111745. Epub 2025 Sep 11. Chem Biol Interact. 2025. PMID: 40945698
The study's objectives were to create, produce, and test vardenafil hydrochloride trihydrate orodispersible tablets in vitro and to see how well they worked in rabbits. ...In comparison to the reference, the optimized formulation also showed better maximum concentra …
The study's objectives were to create, produce, and test vardenafil hydrochloride trihydrate orodispersible tablets in vitro a …
Pharmacokinetics of a new orodispersible tablet formulation of vardenafil: results of three clinical trials.
Heinig R, Weimann B, Dietrich H, Böttcher MF. Heinig R, et al. Clin Drug Investig. 2011;31(1):27-41. doi: 10.2165/11584950-000000000-00000. Clin Drug Investig. 2011. PMID: 20925442 Clinical Trial.
Multiple dosing or administration of vardenafil ODT with food had no meaningful effect on the pharmacokinetics of vardenafil. Vardenafil ODT was well tolerated. CONCLUSION: Vardenafil ODT should be taken without water. ...
Multiple dosing or administration of vardenafil ODT with food had no meaningful effect on the pharmacokinetics of vardenafil. …
Time of onset of vardenafil orodispersible tablet in a real-life setting - looking beyond randomized clinical trials.
Capogrosso P, Ventimiglia E, Boeri L, Serino A, Russo A, La Croce G, Capitanio U, Dehò F, Montorsi F, Salonia A. Capogrosso P, et al. Expert Rev Clin Pharmacol. 2017 Mar;10(3):339-344. doi: 10.1080/17512433.2017.1288567. Epub 2017 Feb 13. Expert Rev Clin Pharmacol. 2017. PMID: 28129714 Free article.
Data from randomized clinical trials (RCTs) showed a rapid onset of action for vardenafil 10 mg orodispersible tablet (ODT). However, the effectiveness of vardenafil ODT has never been tested in a real-life setting. We assessed the efficacy and time to onset …
Data from randomized clinical trials (RCTs) showed a rapid onset of action for vardenafil 10 mg orodispersible tablet (ODT). H …
Time to onset of action of vardenafil: a retrospective analysis of the pivotal trials for the orodispersible and film-coated tablet formulations.
Debruyne FM, Gittelman M, Sperling H, Börner M, Beneke M. Debruyne FM, et al. J Sex Med. 2011 Oct;8(10):2912-23. doi: 10.1111/j.1743-6109.2011.02462.x. Epub 2011 Aug 30. J Sex Med. 2011. PMID: 21883954 Clinical Trial.
AIM: To investigate the time to onset of action of a new orodispersible tablet (ODT) formulation of vardenafil. METHODS: A post hoc integrated analysis was performed on data from two 12-week, double-blind, multicenter, randomized, parallel-group, placebo-controlled …
AIM: To investigate the time to onset of action of a new orodispersible tablet (ODT) formulation of vardenafil. METHODS: A pos …
Dual-purpose vardenafil hydrochloride/dapoxetine hydrochloride orodispersible tablets: in vitro formulation/evaluation, stability study and in vivo comparative pharmacokinetic study in healthy human subjects.
El-Refai K, Teaima MH, El-Nabarawi MA. El-Refai K, et al. Drug Dev Ind Pharm. 2018 Jun;44(6):988-1000. doi: 10.1080/03639045.2018.1427761. Epub 2018 Jan 22. Drug Dev Ind Pharm. 2018. PMID: 29325456
Erectile dysfunction (ED) is the most important disorder after premature ejaculation for sexual activity in men. Vardenafil hydrochloride (VH) is an oral therapy for the treatment of erectile dysfunction. ...
Erectile dysfunction (ED) is the most important disorder after premature ejaculation for sexual activity in men. Vardenafil hydrochlo …
An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study.
Boddi V, Castellini G, Casale H, Rastrelli G, Boni L, Corona G, Maggi M. Boddi V, et al. Andrology. 2015 Sep;3(5):909-18. doi: 10.1111/andr.12079. Andrology. 2015. PMID: 26311340 Free article. Clinical Trial.
In a randomized controlled pilot study, we compared the efficacy of combined vardenafil orodispersible tablet (VARD) and cognitive-behavioral sex therapy (CBST) vs. VARD alone in improving sexual symptoms in both male and female partners. ...
In a randomized controlled pilot study, we compared the efficacy of combined vardenafil orodispersible tablet (VARD) and cogni …
The POTENT I randomized trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
Sperling H, Debruyne F, Boermans A, Beneke M, Ulbrich E, Ewald S. Sperling H, et al. J Sex Med. 2010 Apr;7(4 Pt 1):1497-507. doi: 10.1111/j.1743-6109.2010.01806.x. Epub 2010 Mar 3. J Sex Med. 2010. PMID: 20233275 Clinical Trial.
INTRODUCTION: Orodispersible tablet (ODT) formulations offer improved convenience over film-coated formulations and are preferred by many patients. ...The incidence and type of treatment-related adverse events with vardenafil 10 mg ODT were comparable with those of …
INTRODUCTION: Orodispersible tablet (ODT) formulations offer improved convenience over film-coated formulations and are preferred by …
The POTENT II randomised trial: efficacy and safety of an orodispersible vardenafil formulation for the treatment of erectile dysfunction.
Gittelman M, McMahon CG, Rodríguez-Rivera JA, Beneke M, Ulbrich E, Ewald S. Gittelman M, et al. Int J Clin Pract. 2010 Apr;64(5):594-603. doi: 10.1111/j.1742-1241.2010.02358.x. Int J Clin Pract. 2010. PMID: 20456213 Clinical Trial.
AIMS: The aim of this study was to investigate the efficacy and safety of 10 mg vardenafil orodispersible tablet (ODT) vs. placebo in a general population of men with erectile dysfunction (ED). ...RESULTS: Of the 473 men enrolled in the study (51.4% aged > or =65 …
AIMS: The aim of this study was to investigate the efficacy and safety of 10 mg vardenafil orodispersible tablet (ODT) vs. pla …
17 results